The low glucose-lowering variability of an insulin is desirable, as fluctuations in glucose levels have been shown to increase the risk of retinopathy and neuropathy in patients with Type 1 diabetes and may induce higher rates of hypoglycaemia 31. The gene discussed is INS; the disease is neuropathy.